ID

31751

Description

Topical Vitamin D3, Diclofenac or a Combination of Both to Treat Basal Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01358045 Sponsor: Maastricht University Medical Center Information provided by (Responsible Party): Maastricht University Medical Center

Lien

https://clinicaltrials.gov/show/NCT01358045

Mots-clés

Versions (2)
  1. 22.09.18 22.09.18 -
  2. 25.09.18 25.09.18 -
Détendeur de droits

Maastricht University Medical Center

Téléchargé le

25. September 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Basal Cell Carcinoma NCT01358045

Anglais

Eligibility Basal Cell Carcinoma NCT01358045

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
minimum age 18 years
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
primary basal cell carcinoma, histologically confirmed
Description

primary basal cell carcinoma, histologically confirmed

Type de données

boolean

Alias
UMLS CUI [1,1]
C1304305
UMLS CUI [1,2]
C0449575
(micro) nodular or superficial histological subtype
Description

(micro) nodular or superficial histological subtype

Type de données

boolean

Alias
UMLS CUI [1]
C0862889
UMLS CUI [2]
C4083056
comorbidities may not interfere with study treatment
Description

comorbidities may not interfere with study treatment

Type de données

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C2348563
UMLS CUI [1,4]
C0332197
capable to understand instructions
Description

capable to understand instructions

Type de données

boolean

Alias
UMLS CUI [1,1]
C2051542
UMLS CUI [1,2]
C0162340
UMLS CUI [1,3]
C2698977
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
age under 18 years
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
tumors located at the h-zone of the face
Description

tumors located at the h-zone of the face

Type de données

boolean

Alias
UMLS CUI [1,1]
C0007117
UMLS CUI [1,2]
C0450429
UMLS CUI [1,3]
C0015450
deficient histological conformation
Description

deficient histological conformation

Type de données

boolean

Alias
UMLS CUI [1,1]
C0679557
UMLS CUI [1,2]
C0332197
proven or suspected malignancy of other organs
Description

proven or suspected malignancy of other organs

Type de données

boolean

Alias
UMLS CUI [1,1]
C0581833
UMLS CUI [1,2]
C0205394
UMLS CUI [1,3]
C0178784
UMLS CUI [2,1]
C0205394
UMLS CUI [2,2]
C0178784
UMLS CUI [2,3]
C0006826
not capable of comprehending instructions
Description

not capable of comprehending instructions

Type de données

boolean

Alias
UMLS CUI [1,1]
C2051542
UMLS CUI [1,2]
C0162340
UMLS CUI [1,3]
C2698977
UMLS CUI [1,4]
C0332197
incompetent
Description

Incompetent

Type de données

boolean

Alias
UMLS CUI [1]
C0231190
use of oral nsaids during the trial period or within 30 days before starting therapy
Description

Recent or current use of oral nsaids

Type de données

boolean

Alias
UMLS CUI [1,1]
C0003211
UMLS CUI [1,2]
C0442027
UMLS CUI [1,3]
C0332185
UMLS CUI [2,1]
C0003211
UMLS CUI [2,2]
C0442027
UMLS CUI [2,3]
C0521116
use of oral vitamin d (containing) supplements during the trial period or within 30 days before starting therapy
Description

Recent or current use of oral vitamin d (containing) supplements

Type de données

boolean

Alias
UMLS CUI [1,1]
C3215522
UMLS CUI [1,2]
C0242297
Retour au début de la page

Similar models

Eligibility Basal Cell Carcinoma NCT01358045

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
minimum age 18 years
boolean
C0001779 (UMLS CUI [1])
primary basal cell carcinoma, histologically confirmed
Item
primary basal cell carcinoma, histologically confirmed
boolean
C1304305 (UMLS CUI [1,1])
C0449575 (UMLS CUI [1,2])
(micro) nodular or superficial histological subtype
Item
(micro) nodular or superficial histological subtype
boolean
C0862889 (UMLS CUI [1])
C4083056 (UMLS CUI [2])
comorbidities may not interfere with study treatment
Item
comorbidities may not interfere with study treatment
boolean
C0009488 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,4])
capable to understand instructions
Item
capable to understand instructions
boolean
C2051542 (UMLS CUI [1,1])
C0162340 (UMLS CUI [1,2])
C2698977 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Age
Item
age under 18 years
boolean
C0001779 (UMLS CUI [1])
tumors located at the h-zone of the face
Item
tumors located at the h-zone of the face
boolean
C0007117 (UMLS CUI [1,1])
C0450429 (UMLS CUI [1,2])
C0015450 (UMLS CUI [1,3])
deficient histological conformation
Item
deficient histological conformation
boolean
C0679557 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
proven or suspected malignancy of other organs
Item
proven or suspected malignancy of other organs
boolean
C0581833 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0178784 (UMLS CUI [1,3])
C0205394 (UMLS CUI [2,1])
C0178784 (UMLS CUI [2,2])
C0006826 (UMLS CUI [2,3])
not capable of comprehending instructions
Item
not capable of comprehending instructions
boolean
C2051542 (UMLS CUI [1,1])
C0162340 (UMLS CUI [1,2])
C2698977 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,4])
Incompetent
Item
incompetent
boolean
C0231190 (UMLS CUI [1])
Recent or current use of oral nsaids
Item
use of oral nsaids during the trial period or within 30 days before starting therapy
boolean
C0003211 (UMLS CUI [1,1])
C0442027 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
C0003211 (UMLS CUI [2,1])
C0442027 (UMLS CUI [2,2])
C0521116 (UMLS CUI [2,3])
Recent or current use of oral vitamin d (containing) supplements
Item
use of oral vitamin d (containing) supplements during the trial period or within 30 days before starting therapy
boolean
C3215522 (UMLS CUI [1,1])
C0242297 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial